MILLON JEAN PIERRE
Known title: DirectorCIK: 0001190016
Associated companies
Transaction History
| CVS | ▲ Buy | Grant | 2,200 | $126K | 11/21/2024 | View on chart |
| CVS | ▲ Buy | Grant | 2,314 | $133K | 5/16/2024 | View on chart |
| CVS | ▲ Buy | Grant | 1,925 | $133K | 11/15/2023 | View on chart |
| CVS | ▲ Buy | Grant | 1,437 | $100K | 5/18/2023 | View on chart |
| CVS | ▲ Buy | Grant | 1,402 | $133K | 11/17/2022 | View on chart |
| CVS | ▲ Buy | Grant | 1,409 | $138K | 5/11/2022 | View on chart |
| CVS | ▲ Buy | Grant | 1,253 | $116K | 11/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.